Latest News - ResMed
Top Corporates Hub
ResMed
ResMed (RMD) Sells MatrixCare To Refocus On Sleep And Respiratory Health
10.07.2026 11:14
ResMed (NYSE:RMD) has agreed to divest its MatrixCare business to a private equity buyer. The deal centers on refocusing the company around its sleep and respiratory health technologies and connected care platform. The transaction reflects a move away from post acute care software toward ResMed's core medical device and digital health operations. For investors watching ResMed, the exit from MatrixCare marks a clear effort to tighten the company’s focus on sleep apnea, respiratory care...
Gapping S&P500 stocks in Wednesday's session
08.07.2026 14:35
Wednesday's session is showcasing interesting market movements in the S&P500 index, with notable gap up and gap down stocks. Stay updated with the gapping S&P500 stocks in today's session.
Resmed sharpens sleep care focus with $490m software business sale
08.07.2026 13:53
Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.
Dow Jones and Nasdaq start lower as Trump says Iran ceasefire 'over'
08.07.2026 12:12
Oil prices spiked following an exchange of strikes between the US and Iran
Here is why Taiwan Semiconductor (TSM) Is Among the Best Stocks in Glen Kacher’s Portfolio
08.07.2026 12:00
Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the 10 Best Stocks to Buy in Glen Kacher’s Light Street Portfolio. As of the quarter ended March 31, 2026, Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) represents 14.40% of Glen Kacher’s Light Street Portfolio. Additionally, the fund holds a put option position valued at $36,904,140 in […]
ResMed Inc (NYSE:RMD) Builds on a Quality Foundation with Strong Profitability and Cash Conversion
08.07.2026 11:20
Explore ResMed (RMD) as a quality investment with 68.2% ROIC, 92% cash conversion, low leverage, and 15.82% EBIT growth, scoring 8/10 in fundamentals.
RBC Capital Maintains Outperform on ResMed, Lowers Price Target to $276
08.07.2026 09:58
RBC Capital analyst Craig Wong-Pan maintains ResMed (NYSE:RMD) with a Outperform and lowers the price target from $321 to $276.
Wells Fargo Maintains Equal-Weight on ResMed, Lowers Price Target to $225
08.07.2026 06:41
Wells Fargo analyst Nathan Treybeck maintains ResMed (NYSE:RMD) with a Equal-Weight and lowers the price target from $227 to $225.
Are Options Traders Betting on a Big Move in ResMed Stock?
29.06.2026 15:22
Investors need to pay close attention to RMD stock based on the movements in the options market lately.
Is ResMed Inc. (RMD) Stock Still a Long-Term Winner as OSA Market Expansion Continues?
25.06.2026 12:40
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. ResMed Inc. (NYSE:RMD) is among the best healthcare stocks. TheFly reported on June 22 that KeyBanc adjusted its price target for RMD to $266 from $290 while maintaining an Overweight rating on the shares. The firm noted that […]
[Latest] Global Neonatal Intensive Care Respiratory Devices Market Size/Share Worth USD 5.7 Billion by 2035 at a 10.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis)
24.06.2026 13:30
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Neonatal Intensive Care Respiratory Devices Market size & share revenue was valued at approximately USD 2.1 Billion in 2025 and is expected to reach USD 2.3 Billion in 2026 and is expected to reach around USD 5.7 Billion by 2035, at a CAGR of 10.5% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Inspirat
1 Oversold Stock Primed to Rebound and 2 We Find Risky
24.06.2026 10:16
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether they’re witnessing fire sales or falling knives.
ResMed (RMD) Stock Valuation Check After Mixed Returns And Undervaluation Signals
15.06.2026 04:17
Recent performance snapshot ResMed (RMD) has drawn investor attention after a period of mixed share performance, with the stock up about 1% over the past day but down over the past week, month, past 3 months and year. That backdrop makes the current fundamentals worth a closer look, including revenue of US$5.54b, net income of US$1.52b and a market value around US$28.13b, alongside a mid range value score of 5. See our latest analysis for ResMed. The latest 1 day share price return of 1.24%...
Is ResMed Inc. (RMD) A Good Stock To Buy Now?
11.06.2026 15:25
Is RMD a good stock to buy? We came across a bullish thesis on ResMed Inc. on r/investing_discussion by Variant_Invest. In this article, we will summarize the bulls’ thesis on RMD. ResMed Inc.’s share was trading at $196.94 as of June 9th. RMD’s trailing and forward P/E were 18.99 and 16.61 respectively according to Yahoo Finance. ResMed […]
ResMed: GLP-1 Threats Are Overstated
11.06.2026 07:05
ResMed's GLP-1 concerns are overstated, and though a portion of market share will be lost, the remaining portion will be more beneficial to profitability. Learn more about RMD stock here.
Is It Time To Reassess ResMed (RMD) After A 25% Share Price Slide?
03.06.2026 12:14
If you are wondering whether ResMed at around US$182.82 is pricing in too much optimism or not enough, you are in the right place to assess what that tag might actually represent. The stock has had a weaker run recently, with the share price down 12.1% over the past week, 10.8% over the past month, and 25.3% year to date, the same decline as over the past year. These moves sit against a backdrop of ongoing interest in sleep and respiratory care solutions and broader discussion around how...
Angelini Ventures Marks First Portfolio Company Exit as ResMed Acquires Noctrix Health for $340 million
03.06.2026 11:40
Noctrix Health acquisition validates Angelini Ventures’ strategy of investing in innovative healthcare companies addressing significant unmet medical needs and advancing connected health Rome, Italy, 3rd June 2026 – Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing innovative solutions in BioTech and HealthTech, announces that portfolio company Noctrix Health has been acquired by ResMed (NYSE: RMD), a global leader in sleep health a
ResMed Acquires Sleep-Related Wearables Developer Noctrix Health From Angelini Industries For $340M
03.06.2026 07:45
Angelini Ventures, the corporate venture firm of Angelini Industries focused on investing in companies developing innovative solutions in BioTech and HealthTech, announces that portfolio company Noctrix Health has been
ResMed Inc. (RMD) Presents at 46th Annual William Blair Growth Stock Conference Prepared Remarks Transcript
03.06.2026 04:04
ResMed Inc. (RMD) 46th Annual William Blair Growth Stock Conference June 2, 2026 5:40 PM EDTCompany ParticipantsMichael Farrell - CEO &...